Polymeric nanocapsules for drug delivery: An overview

Colloids in Drug Delivery

Volumn , Issue , 2016, Pages 71-98

  Guterres, Sílvia S ^a   Poletto, Fernanda S ^a   Colomé, Letícia M ^a   Raffin, Renata P ^a   Pohlmann, Adriana R ^a  

^a FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

NANOCAPSULES;

POLYMERIC NANOCAPSULES;

DRUG DELIVERY;

EID: 85051163284     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (145)

1. Aboubakar, M., F. Puisieux, P. Couvreur, M. Deyme, and C. Vauthier, 1999. Study of the mechanism of insulin encapsulation in poly(isobutylcyanoacrylate) nanocapsules obtained by interfacial polymerization. Journal of Biomedical Materials Research 47 (4): 568-576.
2. Allard, E., C. Passirani, E. Garcion, P. Pigeon, A. Vessieres, G. Jaouen, and J. P. Benoit, 2008. Lipid nanocapsules loaded with an organometallic tamoxifen derivative as a novel drug-carrier system for experimental malignant gliomas. Journal of Controlled Release 130 (2): 146-153.
3. Alvarez-Roman, R., G. Barre, R. H. Guy, and H. Fessi, 2001. Biodegradable polymer nanocapsules containing a sunscreen agent: Preparation and photoprotection. European Journal of Pharmaceutics and Biopharmaceutics 52 (2): 191-195.
4. Alves, M. P., A. L. Scarrone, M. Santos, A. R. Pohlmann, and S. S. Guterres, 2007. Human skin penetration and distribution of nimesulide from hydrophilic gels containing nanocarriers. International Journal of Pharmaceutics 341 (1-2): 215-220.
5. Ameller, T., W. Marsaud, P. Legrand, R. Gref, and J. M. Renoir, 2003. In vitro and in vivo biologic evaluation of long-circulating biodegradable drug carriers loaded with the pure antiestrogen RU 58668. International Journal of Cancer 106 (3): 446-454.
6. Ammoury, N., H. Fessi, J. P. Devissaguet, M. Dubrasquet, and S. Benita, 1991. Jejunal-absorption, pharmacological activity, and pharmacokinetic evaluation of indomethacin-loaded poly(d,l-lactide) and poly(isobutylcyanoacrylate) nanocapsules in rats. Pharmaceutical Research 8 (1): 101-105.
7. Ammoury, N., M. Dubrasquet, H. Fessi, J. Ph. Devissaguet, F. Puisieux, and S. Benita, 1993. Indomethacinloaded poly(d,l-lactide) nanocapsules: Protection from gastrointestinal ulcerations and anti-inflammatory activity evaluation in rats. Clinical Materials 13 (1-4): 121-130.
8. Andreopoulos, A. G., E. Hatzi, and M. Doxastakis, 1999. Synthesis and properties of poly(lactic acid). Journal of Materials Science-Materials in Medicine 10 (1): 29-33.
9. Anton, N., J. P. Benoit, and P. Saulnier, 2008. Design and production of nanoparticles formulated from nanoemulsion templates-A review. Journal of Controlled Release 128 (3): 185-199.
10. Bae, K. H., Y. Lee, and T. G. Park, 2007. Oil-encapsulating PEO-PPO-PEO/PEG shell cross-linked nanocapsules for target-specific delivery of paclitaxel. Biomacromolecules 8 (2): 650-656.
11. Beck, R. C. R., A. R. Pohlmann, E. V. Benvenutti, T. D. Costa, and S. S. Guterres, 2005. Nanostructure-coated diclofenac-loaded microparticles: Preparation, morphological characterization, in vitro release and in vivo gastrointestinal tolerance. Journal of the Brazilian Chemical Society 16 (6A): 1233-1240.
12. Beck, R. C. R., S. E. Haas, S. S. Guterres, M. I. Re, E. V. Benvenutti, and A. R. Pohlmann, 2006. Nanoparticlecoated organic-inorganic microparticles: Experimental design and gastrointestinal tolerance evaluation. Quimica Nova 29 (5): 990-996.
13. Beck, R. C. R., A. R. Pohlmann, and S. S. Guterres, 2004. Nanoparticle-coated microparticles: Preparation and characterization. Journal of Microencapsulation 21 (5): 499-512.
14. Beck, R. C. R., A. R. Pohlmann, C. Hoffmeister, M. R. Gallas, E. Collnot, U. F. Schaefer, S. S. Guterres, and C. M. Lehr, 2007. Dexamethasone-loaded nanoparticle-coated microparticles: Correlation between in vitro drug release and drug transport across Caco-2 cell monolayers. European Journal of Pharmaceutics and Biopharmaceutics 67 (1): 18-30.
15. Behr, J. P., B. Demeneix, J. P. Loeffler, and J. P. Mutul, 1989. Efficient gene-transfer into mammalian primary endocrine-cells with lipopolyamine-coated DNA. Proceedings of the National Academy of Sciences of the United States of America 86 (18): 6982-6986.
16. Bernardi, A., R. L. Frozza, E. Jager, F. Figueiro, L. Bavaresco, C. Salbego, A. R. Pohlmann, S. S. Guterres, and A. M. O. Battastini, 2008. Selective cytotoxicity of indomethacin and indomethacin ethyl ester-loaded nanocapsules against glioma cell lines: An in vitro study. European Journal of Pharmacology 586 (1-3): 24-34.
17. Blouza, I. L., C. Charcosset, S. Sfar, and H. Fessi, 2006. Preparation and characterization of spironolactoneloaded nanocapsules for paediatric use. International Journal of Pharmaceutics 325 (1-2): 124-131.
18. Bouchemal, K., S. Briancon, E. Perrier, and H. Fessi, 2004. Nano-emulsion formulation using spontaneous emulsification: Solvent, oil and surfactant optimisation. International Journal of Pharmaceutics 280 (1-2): 241-251.
19. Bourdon, O., I. Laville, D. Carrez, A. Croisy, P. Fedel, A. Kasselouri, P. Prognon, P. Legrand, and J. Blais, 2002. Biodistribution of meta-tetra(hydroxyphenyl)chlorin incorporated into surface-modified nanocapsules in tumor-bearing mice. Photochemical & Photobiological Sciences 1 (9): 709-714.
20. Bourdon, O., V. Mosqueira, P. Legrand, and J. Blais, 2000. A comparative study of the cellular uptake, localization and phototoxicity of meta-tetra(hydroxyphenyl) chlorin encapsulated in surface-modified submicronic oil/water carriers in HT29 tumor cells. Journal of Photochemistry and Photobiology B: Biology 55 (2-3): 164-171.
21. Calvo, P., M. J. Alonso, J. L. VilaJato, and J. R. Robinson, 1996c. Improved ocular bioavailability of indomethacin by novel ocular drug carriers. Journal of Pharmacy and Pharmacology 48 (11): 1147-1152.
22. Calvo, P., A. Sanchez, J. Martinez, M. I. Lopez, M. Calonge, J. C. Pastor, and M. J. Alonso, 1996b. Polyester nanocapsules as new topical ocular delivery systems for cyclosporin A. Pharmaceutical Research 13 (2): 311-315.
23. Calvo, P., J. L. VilaJato, and M. J. Alonso, 1996a. Comparative in vitro evaluation of several colloidal systems, nanoparticles, nanocapsules, and nanoemulsions, as ocular drug carriers. Journal of Pharmaceutical Sciences 85 (5): 530-536.
24. Calvo, P., J. P. VilaJato, and M. J. Alonso, 1997. Evaluation of cationic polymer-coated nanocapsules as ocular drug carriers. International Journal of Pharmaceutics 153 (1): 41-50.
25. Cattani, V. B., A. R. Pohlmann, and T. D. Costa, 2008. Pharmacokinetic evaluation of indomethacin ethyl esterloaded nanoencapsules. International Journal of Pharmaceutics 363 (1-2): 214-216.
26. Cauchetier, E., M. Deniau, H. Fessi, A. Astier, and M. Paul, 2003b. Atovaquone-loaded nanocapsules: Influence of the nature of the polymer on their in vitro characteristics. International Journal of Pharmaceutics 250 (1): 273-281.
27. Cauchetier, E., M. Paul, D. Rlvollett, H. Fessit, A. Astier, and M. Deniau, 2003a. Therapeutic evaluation of free and nanocapsule-encapsulated atovaquone in the treatment of murine visceral leishmaniasis. Annals of Tropical Medicine and Parasitology 97 (3): 259-268.
28. Cha, Y. and C. G. Pitt, 1988. A one-week subdermal delivery system for l-methadone based on biodegradable microcapsules. Journal of Controlled Release 7 (1): 69-78.
29. Choi, S. W., H. Y. Kwon, W. S. Kim, and J. H. Kim, 2002. Thermodynamic parameters on poly(d,l-lactide-coglycolide) particle size in emulsification-diffusion process. Colloids and Surfaces A: Physicochemical and Engineering Aspects 201 (1-3): 283-289.
30. Cournarie, F., D. Auchere, D. Chevenne, B. Lacour, M. Seiller, and C. Vauthier, 2002. Absorption and efficiency of insulin after oral administration of insulin-loaded nanocapsules in diabetic rats. International Journal of Pharmaceutics 242 (1-2): 325-328.
31. Couvreur, P., G. Barratt, E. Fattal, P. Legrand, and C. Vauthier, 2002. Nanocapsule technology: A review. Critical Reviews in Therapeutic Drug Carrier Systems 19 (2): 99-134.
32. Couvreur, P., L. Roblot-Treupel, M. F. Poupon, F. Brasseur, and F. Puisieux, 1990. Nanoparticles as microcarriers for anticancer drugs. Advanced Drug Delivery Reviews 5 (3): 209-230.
33. Couvreur, P. and C. Vauthier, 2006. Nanotechnology: Intelligent design to treat complex disease. Pharmaceutical Research 23 (7): 1417-1450.
34. Cruz, L., S. R. Schaffazick, T. Dalla Costa, L. U. Soares, G. Mezzalira, N. P. da Silveira, E. E. S. Schapoval, A. R. Pohlmann, and S. S. Guterres, 2006a. Physico-chemical characterization and in vivo evaluation of indomethacin ethyl ester-loaded nanocapsules by PCS, TEM, SAXS, interfacial alkaline hydrolysis and antiedematogenic activity. Journal of Nanoscience and Nanotechnology 6 (9-10): 3154-3162.
35. Cruz, L., L. U. Soares, T. D. Costa, G. Mezzalira, N. P. da Silveira, S. S. Guterres, and A. R. Pohlmann, 2006b. Diffusion and mathematical modeling of release profiles from nanocarriers. International Journal of Pharmaceutics 313 (1-2): 198-205.
36. da Fonseca, L. S., R. P. Silveira, A. M. Deboni, E. V. Benvenutti, T. M. H. Costa, S. S. Guterres, and A. R. Pohlmann, 2008. Nanocapsule-xerogel microparticles containing sodium diclofenac: A new strategy to control the release of drugs. International Journal of Pharmaceutics 358 (1-2): 292-295.
37. Damge, C., D. Hillairebuys, R. Puech, A. Hoeltzel, C. Michel, and G. Ribes, 1995. Effects of orally-administered insulin nanocapsules in normal and diabetic dogs. Diabetes Nutrition & Metabolism 8 (1): 3-9.
38. Damge, C., C. Michel, M. Aprahamian, and P. Couvreur, 1988. New approach for oral-administration of insulin with polyalkylcyanoacrylate nanocapsules as drug carrier. Diabetes 37 (2): 246-251.
39. Date, A. A., M. D. Joshi, and V. B. Patravale, 2007. Parasitic diseases: Liposomes and polymeric nanoparticles versus lipid nanoparticles. Advanced Drug Delivery Reviews 59: 505-521.
40. de Assis, D. N., V. C. F. Mosqueira, J. M. C. Vilela, M. S. Andrade, and V. N. Cardoso, 2008. Release profiles and morphological characterization by atomic force microscopy and photon correlation spectroscopy of (99 m) technetium-fluconazole nanocapsules. International Journal of Pharmaceutics 349 (1-2): 152-160.
41. Delgado, A. V., E. Gonzalez-Caballero, R. J. Hunter, L. K. Koopal, and J. Lyklema, 2005. Measurement and interpretation of electrokinetic phenomena (IUPAC technical report). Pure and Applied Chemistry 77 (10): 1753-1805.
42. Desai, S. D. and J. Blanchard, 2000. PluronicR F127-based ocular delivery system containing biodegradable polyisobutylcyanoacrylate nanocapsules of pilocarpine. Drug Delivery 7 (4): 201-207.
43. Dodou, D., P. Breedveld, and P. A. Wieringa, 2005. Mucoadhesives in the gastrointestinal tract: Revisiting the literature for novel applications. European Journal of Pharmaceutics and Biopharmaceutics 60 (1): 1-16.
44. Daoud-Mahammed, S., P. Couvreur, and R. Gref, 2007. Novel self-assembling nanogels: Stability and lyophilisation studies. International Journal of Pharmaceutics 332 (1-2): 185-191.
45. Fawaz, F., F. Bonini, M. Guyot, A. M. Lagueny, H. Fessi, and J. P. Devissaguet, 1996. Disposition and protective effect against irritation after intravenous and rectal administration of indomethacin loaded nanocapsules to rabbits. International Journal of Pharmaceutics 133 (1-2): 107-115.
46. Felgner, P. L., T. R. Gadek, M. Holm, R. Roman, H. W. Chan, M. Wenz, J. P. Northrop, G. M. Ringold, and M. Danielsen, 1987. Lipofection-A highly efficient, lipid-mediated DNA-transfection procedure. Proceedings of the National Academy of Sciences of the United States of America 84 (21): 7413-7417.
47. Fessi, H., F. Puisieux, J. P. Devissaguet, N. Ammoury, and S. Benita, 1989. Nanocapsule formation by interfacial polymer deposition following solvent displacement. International Journal of Pharmaceutics 55 (1): R1-R4.
48. Frank, M. M. and L. F. Fries, 1991. The role of complement in inflammation and phagocytosis. Immunology Today 12 (9): 322-326.
49. Fresta, M., G. Cavallaro, G. Giammona, E. Wehrli, and G. Puglisi, 1996. Preparation and characterization of polyethyl-2-cyanoacrylate nanocapsules containing antiepileptic drugs. Biomaterials 17 (8): 751-758.
50. Friedrich, R. B., M. C. Fontana, R. C. R. Beck, A. R. Pohlmann, and S. S. Guterres, 2008. Development and physicochemical characterization of dexamethasone-loaded polymeric nanocapsule suspensions. Química Nova 31 (5): 1131-1136.
51. Gallardo, M., G. Couarraze, B. Denizot, L. Treupel, P. Couvreur, and F. Puisieux, 1993. Study of the mechanisms of formation of nanoparticles and nanocapsules of polyisobutyl-2-cyanoacrylate. International Journal of Pharmaceutics 100 (1-3): 55-64.
52. Ganachaud, F. and J. L. Katz, 2005. Nanoparticles and nanocapsules created using the Ouzo effect: Spontaneous emulsification as an alternative to ultrasonic and high-shear devices. Chemphyschem 6 (2): 209-216.
53. Garcion, E., A. Lamprecht, B. Heurtault, A. Paillard, A. Aubert-Pouessel, B. Denizot, P. Menei, and J. P. Benoit, 2006. A new generation of anticancer, drug-loaded, colloidal vectors reverses multidrug resistance in glioma and reduces tumor progression in rats. Molecular Cancer Therapeutics 5 (7): 1710-1722.
54. Gaumet, M., A. Vargas, R. Gurny, and F. Delie, 2008. Nanoparticles for drug delivery: The need for precision in reporting particle size parameters. European Journal of Pharmaceutics and Biopharmaceutics 69 (1): 1-9.
55. Gref, R., Y. Minamitake, M. T. Peracchia, V. Trubetskoy, V. Torchilin, and R. Langer, 1994. Biodegradable long-circulating polymeric nanospheres. Science 263 (5153): 1600-1603.
56. Guinebretiere, S., S. Briancon, H. Fessi, V. S. Teodorescu, and M. G. Blanchin, 2002. Nanocapsules of biodegradable polymers: Preparation and characterization by direct high resolution electron microscopy. Materials Science and Engineering C: Biomimetic and Supramolecular Systems 21 (1-2): 137-142.
57. Gursoy, A., L. Eroglu, S. Ulutin, M. Tasyurek, H. Fessi, F. Puisieux, and J. P. Devissaguet, 1989. Evaluation of indomethacin nanocapsules for their physical stability and inhibitory activity on inflammation and platelet- aggregation. International Journal of Pharmaceutics 52 (2): 101-108.
58. Guterres, S. S., H. Fessi, G. Barratt, J. P. Devissaguet, and F. Puisieux, 1995a. Poly(d,l-lactide) nanocapsules containing diclofenac. 1. Formulation and stability study. International Journal of Pharmaceutics 113 (1): 57-63.
59. Guterres, S. S., H. Fessi, G. Barratt, F. Puisieux, and J. P. Devissaguet, 1995b. Poly(d,l-lactide) nanocapsules containing nonsteroidal antiinflammatory drugs-Gastrointestinal tolerance following intravenous and oral-administration. Pharmaceutical Research 12 (10): 1545-1547.
60. Guterres, S. S., C. R. Muller, C. B. Michalowski, A. R. Pohlmann, and T. Dalla Costa, 2001. Gastro-intestinal tolerance following oral administration of spray-dried diclofenac-loaded nanocapsules and nanospheres. STP Pharma Sciences 11 (3): 229-233.
61. Guterres, S. S., V. Weiss, L. D. Freitas, and A. R. Pohlmann, 2000. Influence of benzyl benzoate as oil core on the physicochemical properties of spray-dried powders from polymeric nanocapsules containing indomethacin. Drug Delivery 7 (4): 195-199.
62. Han, M., E. Lee, and E. Kim, 2003. Preparation and optical properties of polystyrene nanocapsules containing photochromophores. Optical Materials 21 (1-3): 579-583.
63. Hoffmann, D. and C. Mayer, 2000. Cross polarization induced by temporary adsorption: NMR investigations on nanocapsule dispersions. Journal of Chemical Physics 112 (9): 4242-4250.
64. Hwang, S. L. and J. C. Kim, 2008. In vivo hair growth promotion effects of cosmetic preparations containing hinokitiol-loaded poly(epsilon-caprolactone) nanocapsules. Journal of Microencapsulation 25 (5): 351-356.
65. Illum, L., L. O. Jacobsen, R. H. Muller, E. Mak, and S. S. Davis, 1987. Surface characteristics and the interaction of colloidal particles with mouse peritoneal-macrophages. Biomaterials 8 (2): 113-117.
66. Jabr-Milane, L., L. van Vlerken, H. Devalapally, D. Shenoy, S. Komareddy, M. Bhavsar, and M. Amiji, 2008. Multi-functional nanocarriers for targeted delivery of drugs and genes. Journal of Controlled Release 130 (2): 121-128.
67. Jager, A., V. Stefani, S. S. Guterres, and A. R. Pohlmann, 2007. Physico-chemical characterization of nanocapsule polymeric wall using fluorescent benzazole probes. International Journal of Pharmaceutics 338 (1-2): 297-305.
68. Kaul, G. and M. Amiji, 2004. Biodistribution and targeting potential of poly(ethylene glycol)-modified gelatin nanoparticles in subcutaneous murine tumor model. Journal of Drug Targeting 12 (9-10): 585-591.
69. Kesisoglou, F., S. Panmai, and Y. H. Wu, 2007. Nanosizing-oral formulation development and biopharmaceutical evaluation. Advanced Drug Delivery Reviews 59: 631-644.
70. Khalid, M. N., P. Simard, D. Hoarau, A. Dragomir, and J. C. Leroux, 2006. Long circulating poly(ethylene glycol)-decorated lipid nanocapsules deliver docetaxel to solid tumors. Pharmaceutical Research 23 (4): 752-758.
71. Koppel, D. E., 1972. Analysis of macromolecular polydispersity in intensity correlation spectroscopy-Method of cumulants. Journal of Chemical Physics 57 (11): 4814-4820.
72. Kriwet, B., E. Walter, and T. Kissel, 1998. Synthesis of bioadhesive poly(acrylic acid) nano- and microparticles using an inverse emulsion polymerization method for the entrapment of hydrophilic drug candidates. Journal of Controlled Release 56 (1-3): 149-158.
73. Lamprecht, A. and J. P. Benoit, 2006. Etoposide nanocarriers suppress glioma cell growth by intracellular drug delivery and simultaneous P-glycoprotein inhibition. Journal of Controlled Release 112 (2): 208-213.
74. Lboutounne, H., J. F. Chaulet, C. Ploton, F. Falson, and F. Pirot, 2002. Sustained ex vivo skin antiseptic activity of chlorhexidine in poly(epsilon-caprolactone) nanocapsule encapsulated form and as a digluconate. Journal of Controlled Release 82 (2-3): 319-334.
75. Leite, E. A., A. Grabe-Guimaraes, H. N. Guimaraes, G. L. L. Machado-Coelho, G. Barratt, and V. C. F. Mosqueira, 2007. Cardiotoxicity reduction induced by halofantrine entrapped in nanocapsule devices. Life Sciences 80 (14): 1327-1334.
76. Lemarchand, C., P. Couvreur, M. Besnard, D. Costantini, and R. Gref, 2003. Novel polyester-polysaccharide nanoparticles. Pharmaceutical Research 20 (8): 1284-1292.
77. Lopes, E., A. R. Pohlmann, V. Bassani, and S. S. Guterres, 2000. Polymeric colloidal systems containing ethionamide: Preparation and physico-chemical characterization. Pharmazie 55 (7): 527-530.
78. Losa, C., L. Marchalheussler, F. Orallo, J. L. V. Jato, and M. J. Alonso, 1993. Design of new formulations for topical ocular administration-Polymeric nanocapsules containing metipranolol. Pharmaceutical Research 10 (1): 80-87.
79. Lozano, M. V., D. Torrecilla, D. Torres, A. Vidal, F. Dominguez, and M. J. Alonso, 2008. Highly efficient system to deliver taxanes into tumor cells: Docetaxel-loaded chitosan oligomer colloidal carriers. Biomacromolecules 9 (8): 2186-2193.
80. Maillard, S., T. Ameller, J. Gauduchon, A. Gougelet, F. Gouilleux, P. Legrand, V. Marsaud, E. Fattal, B. Sola, and J. M. Renoir, 2005. Innovative drug delivery nanosystems improve the anti-tumor activity in vitro and in vivo of anti-estrogens in human breast cancer and multiple myeloma. Journal of Steroid Biochemistry and Molecular Biology 94 (1-3): 111-121.
81. Masters, K., 1991. Spray Drying Handbook, 1st edition. Harlow, England: Longman Scientific and Technical.
82. Matoga, M., F. Pehourcq, F. Lagrange, F. Fawaz, and B. Bannwarth, 2002. Influence of a polymeric formulation of ketoprofen on its diffusion into cerebrospinal fluid in rats. Journal of Pharmaceutical and Biomedical Analysis 27 (6): 881-888.
83. Mayer, C., D. Hoffmann, and M. Wohlgemuth, 2002. Structural analysis of nanocapsules by nuclear magnetic resonance. International Journal of Pharmaceutics 242 (1-2): 37-46.
84. Michel, C., M. Aprahamian, L. Defontaine, P. Couvreur, and C. Damge, 1991. The effect of site of administration in the gastrointestinal-tract on the absorption of insulin from nanocapsules in diabetic rats. Journal of Pharmacy and Pharmacology 43 (1): 1-5.
85. Middleton, J. C. and A. J. Tipton, 2000. Synthetic biodegradable polymers as orthopedic devices. Biomaterials 21 (23): 2335-2346.
86. Milao, D., M. T. Knorst, W. Richter, and S. S. Guterres, 2003. Hydrophilic gel containing nanocapsules of diclofenac:Development, stability study and physico-chemical characterization. Pharmazie 58 (5): 325-329.
87. Moghimi, S. M., I. S. Muir, L. Illum, S. S. Davis, and V. Kolb-Bachofen, 1993. Coating particles with a block co-polymer (poloxamine-908) suppresses opsonization but permits the activity of dysopsonins in the serum. Biochimica et Biophysica Acta 1179 (2): 157-165.
88. Moinard-Checot, D., Y. Chevalier, S. Briancon, L. Beney, and H. Fessi, 2008. Mechanism of nanocapsules formation by the emulsion-diffusion process. Journal of Colloid and Interface Science 317 (2): 458-468.
89. Montasser, I., S. Briancon, and H. Fessi, 2007. The effect of monomers on the formulation of polymeric nanocapsules based on polyureas and polyamides. International Journal of Pharmaceutics 335 (1-2): 176-179.
90. Mosqueira, V. C. F., P. Legrand, H. Pinto-Alphandary, F. Puisieux, and G. Barratt, 2000. Poly(d,l-lactide) nanocapsules prepared by a solvent displacement process: Influence of the composition on physicochemical and structural properties. Journal of Pharmaceutical Sciences 89 (5): 614-626.
91. Mosqueira, V. C. F., P. M. Loiseau, C. Bories, P. Legrand, J. P. Devissaguet, and G. Barratt, 2004. Efficacy and pharmacokinetics of intravenous nanocapsule formulations of halofantrine in Plasmodium berghei infected mice. Antimicrobial Agents and Chemotherapy 48 (4): 1222-1228.
92. Muller, C. R., V. L. Bassani, A. R. Pohlmann, C. B. Michalowski, P. R. Petrovick, and S. S. Guterres, 2000. Preparation and characterization of spray-dried polymeric nanocapsules. Drug Development and Industrial Pharmacy 26 (3): 343-347.
93. Muller, C. R., S. E. Haas, V. L. Bassani, S. S. Guterres, H. Fessi, M. Peralba, and A. R. Pohlmann, 2004. Degradation and stabilization of diclofenac in polymeric nanocapsules. Quimica Nova 27 (4): 555-560.
94. Muller, C. R., S. R. Schaffazick, A. R. Pohlmann, L. D. Freitas, N. P. da Silveira, T. D. Costa, and S. S. Guterres, 2001. Spray-dried diclofenac-loaded poly(epsilon-caprolactone) nanocapsules and nanospheres. Preparation and physicochemical characterization. Pharmazie 56 (11): 864-867.
95. Nguyen, A., V. Marsaud, C. Bouclier, S. Top, A. Vessieres, P. Pigeon, R. Gref, P. Legrand, G. Jaouen, and J. M. Renoir, 2008. Nanoparticles loaded with ferrocenyl tamoxifen derivatives for breast cancer treatment. International Journal of Pharmaceutics 347 (1-2): 128-135.
96. Nhung, D. T. T., A. M. Freydiere, H. Constant, F. Falson, and F. Pirot, 2007. Sustained antibacterial effect of a hand rub gel incorporating chlorhexdine-loaded nanocapsules (Nanochlorex(R)). International Journal of Pharmaceutics 334 (1-2): 166-172.
97. Olvera-Martinez, B. I., J. Cazares-Delgadillo, S. B. Calderilla-Faardo, R. Villalobos-Garcia, A. Ganem-Quintanar, and D. Quintanar-Guerrero, 2005. Preparation of polymeric nanocapsules containing octyl methoxycinnamate by the emulsification-diffusion technique: Penetration across the stratum corneum. Journal of Pharmaceutical Sciences 94 (7): 1552-1559.
98. Ourique, A. F., A. R. Pohlmann, S. S. Guterres, and R. C. R. Beck, 2008. Tretinoin-loaded nanocapsules:Preparation, physicochemical characterization, and photostability study. International Journal of Pharmaceutics 352 (1-2): 1-4.
99. Owens, D. E. and N. A. Peppas, 2006. Opsonization, biodistribution, and pharmacokinetics of polymeric nanoparticles. International Journal of Pharmaceutics 307 (1): 93-102.
100. Palumbo, M., A. Russo, V. Cardile, M. Renis, D. Paolino, G. Puglisi, and M. Fresta, 2002. Improved antioxidant effect of idebenone-loaded polyethyl-2-cyanoacrylate nanocapsules tested on human fibroblasts. Pharmaceutical Research 19 (1): 71-78.
101. Peracchia, M. T., S. Harnisch, H. Pinto-Alphandary, A. Gulik, J. C. Dedieu, D. Desmaele, J. d'Angelo, R. H. Muller, and P. Couvreur, 1999. Visualization of in vitro protein-rejecting properties of PEGylated StealthR polycyanoacrylate nanoparticles. Biomaterials 20 (14): 1269-1275.
102. Pinto-Alphandary, H., M. Aboubakar, D. Jaillard, P. Couvreur, and C. Vauthier, 2003. Visualization of insulinloaded nanocapsules: In vitro and in vivo studies after oral administration to rats. Pharmaceutical Research 20 (7): 1071-1084.
103. Pisani, E., N. Tsapis, J. Paris, V. Nicolas, L. Cattel, and E. Fattal, 2006. Polymeric nano/microcapsules of liquid perfluorocarbons for ultrasonic imaging: Physical characterization. Langmuir 22 (9): 4397-4402.
104. Pisani, E., E. Fattal, J. Paris, C. Ringard, V. Rosilio, and N. Tsapis, 2008. Surfactant dependent morphology of polymeric capsules of perfluorooctyl bromide: Influence of polymer adsorption at the dichloromethane- water interface. Journal of Colloid and Interface Science 326 (1): 66-71.
105. Pohlmann, A. R., G. Mezzalira, C. D. Venturini, L. Cruz, A. Bernardi, E. Jager, A. M. O. Battastini, N. P. da Silveira, and S. S. Guterres, 2008. Determining the simultaneous presence of drug nanocrystals in drugloaded polymeric nanocapsule aqueous suspensions: A relation between light scattering and drug content. International Journal of Pharmaceutics 359 (1-2): 288-293.
106. Pohlmann, A. R., L. U. Soares, L. Cruz, N. P. da Silveira, and S. S. Guterres, 2004. Alkaline hydrolysis as a tool to determine the association form of indomethacin in nanocapsules prepared with poly(ε-caprolactone). Current Drug Delivery 1 (2): 103-110.
107. Pohlmann, A. R., V. Weiss, O. Mertins, N. P. da Silveira, and S. S. Guterres, 2002. Spray-dried indomethacinloaded polyester nanocapsules and nanospheres: Development, stability evaluation and nanostructure models. European Journal of Pharmaceutical Sciences 16 (4-5): 305-312.
108. Poletto, F. S., L. A. Fiel, B. Donida, M. I. Re, S. S. Guterres, and A. R. Pohlmann, 2008a. Controlling the size of poly(hydroxybutyrate-co-hydroxyvalerate) nanoparticles prepared by emulsification-diffusion technique using ethanol as surface agent. Colloids and Surfaces A: Physicochemical and Engineering Aspects 324 (1-3): 105-112.
109. Poletto, F. S., E. Jaeger, L. Cruz, A. R. Pohlmann, and S. S. Guterres, 2008b. The effect of polymeric wall on the permeability of drug-loaded nanocapsules. Materials Science and Engineering C: Biomimetic and Supramolecular Systems 28 (4): 472-478.
110. Preetz, C., A. Rube, I. Reiche, G. Hause, and K. Mader, 2008. Preparation and characterization of biocompatible oil-loaded polyelectrolyte nanocapsules. Nanomedicine: Nanotechnology, Biology, and Medicine 4 (2): 106-114.
111. Prego, C., M. Fabre, D. Torres, and M. J. Alonso, 2006b. Efficacy and mechanism of action of chitosan nanocapsules for oral peptide delivery. Pharmaceutical Research 23 (3): 549-556.
112. Prego, C., D. Torres, E. Fernandez-Megia, R. Novoa-Carballal, E. Quinoa, and M. J. Alonso, 2006a. Chitosan-PEG nanocapsules as new carriers for oral peptide delivery-Effect of chitosan PEGylation degree. Journal of Controlled Release 111 (3): 299-308.
113. Quintanar-Guerrero, D., E. Allemann, E. Doelker, and H. Fessi, 1998. Preparation and characterization of nanocapsules from preformed polymers by a new process based on emulsification-diffusion technique. Pharmaceutical Research 15 (7): 1056-1062.
114. Quintanar-Guerrero, D., H. Fessi, E. Allemann, and E. Doelker, 1996. Influence of stabilizing agents and preparative variables on the formation of poly(d,l-lactic acid) nanoparticles by an emulsification- diffusion technique. International Journal of Pharmaceutics 143 (2): 133-141.
115. Raffin, R. P., E. S. Obach, G. Mezzalira, A. R. Pohlmann, and S. S. Guterres, 2003. Dried nanocapsules containing indomethacin: Formulation study and gastrointestinal tolerance evaluation in rats. Acta Farmaceutica Bonaerense 22 (2): 163-172.
116. Renoir, J. M., B. Stella, T. Ameller, E. Connault, P. Opolon, and V. Marsaud, 2006. Improved anti-tumoral capacity of mixed and pure anti-oestrogens in breast cancer cell xenografts after their administration by entrapment in colloidal nanosystems. Journal of Steroid Biochemistry and Molecular Biology 102 (1-5): 114-127.
117. Reynolds, J. E. F., 1993. Martindale: The Extra Pharmacopoeia, 30th edition. London: Pharmaceutical Press.
118. Romero-Cano, M. S. and B. Vincent, 2002. Controlled release of 4-nitroanisole from poly(lactic acid) nanoparticles. Journal of Controlled Release 82 (1): 127-135.
119. Rube, A., G. Hause, K. Mader, and J. Kohlbrecher, 2005. Core-shell structure of Miglyol/poly(d,l-lactide)/ Poloxamer nanocapsules studied by small-angle neutron scattering. Journal of Controlled Release 107 (2): 244-252.
120. Saez, A., M. Guzman, J. Molpeceres, and M. R. Aberturas, 2000. Freeze-drying of polycaprolactone and poly(d,l-lactic-glycolic) nanoparticles induce minor particle size changes affecting the oral pharmacokinetics of loaded drugs. European Journal of Pharmaceutics and Biopharmaceutics 50 (3): 379-387.
121. Saffran, M., B. Pansky, G. C. Budd, and F. E. Williams, 1997. Insulin and the gastrointestinal tract. Journal of Controlled Release 46 (1-2): 89-98.
122. Sai, P., C. Damge, A. S. Rivereau, A. Hoeltzel, and E. Gouin, 1996. Prophylactic oral administration of metabolically active insulin entrapped in isobutylcyanoacrylate nanocapsules reduces the incidence of diabetes in nonobese diabetic mice. Journal of Autoimmunity 9 (6): 713-722.
123. Santos-Magalhaes, N. S., A. Pontes, V. M. W. Pereira, and M. N. P. Caetano, 2000. Colloidal carriers for benzathine penicillin G: Nanoemulsions and nanocapsules. International Journal of Pharmaceutics 208 (1-2): 71-80.
124. Schaffazick, S. R., A. R. Pohlmann, T. Dalla-Costa, and S. S. Guterres, 2003b. Freeze-drying polymeric colloidal suspensions: Nanocapsules, nanospheres and nanodispersion. A comparative study. European Journal of Pharmaceutics and Biopharmaceutics 56 (3): 501-505.
125. Schaffazick, S. R., A. R. Pohlmann, C. A. S. de Cordova, T. B. Creczynski-Pasa, and S. S. Guterres, 2005. Protective properties of melatonin-loaded nanoparticles against lipid peroxidation. International Journal of Pharmaceutics 289 (1-2): 209-213.
126. Schaffazick, S. R., A. R. Pohlmann, and S. S. Guterres, 2007. Nanocapsules, nanoemulsion and nanodispersion containing melatonin: Preparation, characterization and stability evaluation. Pharmazie 62 (5): 354-360.
127. Schaffazick, S. R., I. R. Siqueira, A. S. Badejo, D. S. Jornada, A. R. Pohlmann, C. A. Netto, and S. S. Guterres, 2008. Incorporation in polymeric nanocapsules improves the antioxidant effect of melatonin against lipid peroxidation in mice brain and liver. European Journal of Pharmaceutics and Biopharmaceutics 69 (1): 64-71.
128. Schaffazick, S. R., S. S. U. Guterres, L. D. Freitas, and A. R. Pohlmann, 2003a. Physicochemical characterization and stability of the polymeric nanoparticle systems for drug administration. Quimica Nova 26 (5): 726-737.
129. Sinha, V. R., K. Bansal, R. Kaushik, R. Kumria, and A. Trehan, 2004. Poly-epsilon-caprolactone microspheres and nanospheres: An overview. International Journal of Pharmaceutics 278 (1): 1-23.
130. Soppimath, K. S., T. M. Aminabhavi, A. R. Kulkarni, and W. E. Rudzinski, 2001. Biodegradable polymeric nanoparticles as drug delivery devices. Journal of Controlled Release 70 (1-2): 1-20.
131. Stella, B., S. Arpicco, F. Rocco, V. Marsaud, J. M. Renoir, L. Cattel, and P. Couvreur, 2007. Encapsulation of gemcitabine lipophilic derivatives into polycyanoacrylate nanospheres and nanocapsules. International Journal of Pharmaceutics 344 (1-2): 71-77.
132. Stolnik, S., L. Illum, and S. S. Davis, 1995. Long circulating microparticulate drug carriers. Advanced Drug Delivery Reviews 16 (2-3): 195-214.
133. Sussman, E. M., M. B. Clarke, and V. P. Shastri, 2007. Single-step process to produce surface-functionalized polymeric nanoparticles. Langmuir 23: 12275-12279.
134. Teixeira, M., M. J. Alonso, M. M. M. Pinto, and C. M. Barbosa, 2005. Development and characterization of PLGA nanospheres and nanocapsules containing xanthone and 3-methoxyxanthone. European Journal of Pharmaceutics and Biopharmaceutics 59 (3): 491-500.
135. Turos, E., J. Y. Shim, Y. Wang, K. Greenhalgh, G. S. K. Reddy, S. Dickey, and D. V. Lim, 2007. Antibioticconjugated polyacrylate nanoparticles: New opportunities for development of anti-MRSA agents. Bioorganic and Medicinal Chemistry Letters 17 (1): 53-56.
136. Vauthier, C., B. Cabane, and D. Labarre, 2008. How to concentrate nanoparticles and avoid aggregation? European Journal of Pharmaceutics and Biopharmaceutics 69 (2): 466-475.
137. Vauthier, C., D. Labarre, and G. Ponchel, 2007. Design aspects of poly(alkylcyanoacrylate) nanoparticles for drug delivery. Journal of Drug Targeting 15 (10): 641-663.
138. Veronese, F. M. and G. Pasut, 2005. PEGylation, successful approach to drug delivery. Drug Discovery Today 10 (21-24): 1451-1458.
139. Vitale, S. A. and J. L. Katz, 2003. Liquid droplet dispersions formed by homogeneous liquid-liquid nucleation:''The ouzo effect." Langmuir 19 (10): 4105-4110.
140. Washington, C., 1990. Drug release from microdisperse systems-A critical review. International Journal of Pharmaceutics 58 (1): 1-12.
141. Watnasirichaikul, S., T. Rades, I. G. Tucker, and N. M. Davies, 2002. In-vitro release and oral bioactivity of insulin in diabetic rats using nanocapsules dispersed in biocompatible microemulsion. Journal of Pharmacy and Pharmacology 54 (4): 473-480.
142. Weiss-Angeli, V., F. S. Poletto, L. R. Zancan, F. Baldasso, A. R. Pohlmann, and S. S. Guterres, 2008. Nanocapsules of octyl methoxycinnamate containing quercetin delayed the photodegradation of both components under ultraviolet A radiation. Journal of Biomedical Nanotechnology 4 (1): 80-89.
143. Wise, D. L., D. J. Trantolo, R. T. Marino, and J. P. Kitchell, 1987. Opportunities and challenges in design of implantable biodegradable polymeric systems for drug delivery of antimicrobial agents and vaccines. Advanced Drug Delivery Reviews 1 (1): 19-40.
144. Zhang, Y., S. Y. Zhu, L. C. Yin, F. Qian, C. Tang, and C. H. Yin, 2008. Preparation, characterization and biocompatibility of poly(ethylene glycol)-poly(n-butyl cyanoacrylate) nanocapsules with oil core via miniemulsion polymerization. European Polymer Journal 44 (6): 1654-1661.
145. Zili, Z., S. Sfar, and H. Fessi, 2005. Preparation and characterization of poly-e-caprolactone nanoparticles containing griseofulvin. International Journal of Pharmaceutics 294 (1-2): 261-267.